New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
Subscribe To Our Newsletter & Stay Updated
